Evaluation of serum lipid profiles, uric acid, and high sensitivity C‐reactive protein levels between pregnancy‐induced hypertension and normotensive pregnant women attending Ambo University Referral Hospital, Ambo, Ethiopia, 2020: A case‐control study
Open Access
- 1 September 2022
- journal article
- research article
- Published by Wiley in Health Science Reports
- Vol. 5 (5) , e806
Abstract
Background and Aims: Pregnancy‐induced hypertension is one of the top three ranked diseases during pregnancy that cause maternal, fetal, and neonatal morbidity and mortality worldwide. To provide adequate information to clinicians and researchers who are striving for potential interventions, biochemical profiling of such patients is required.Methods: A hospital‐based case‐control study design was conducted from August 2020 to May 2021 to evaluate serum lipid profile, uric acid, and high sensitivity C‐reactive protein (hs‐CRP) among women with pregnancy‐induced hypertension compared to normotensive pregnant women. Data were entered and analyzed using SPSS version 25. Independent t‐test and χ2 were used to compare the relationship of variables between the two groups. A p‐value less than 0.05 was used to test statistical significance.Results: The result of this study showed that while the levels (mean ± SD) of serum total cholesterol (TC), triglyceride (TG), low‐density lipoprotein‐cholesterol (LDL‐C), TC/high‐density lipoprotein‐cholesterol (HDL‐C), TG/HDL‐C, LDL‐C/HDL‐C were significantly elevated, HDL‐C was decreased among women with pregnancy‐induced hypertension than normotensive pregnant women (p < 0.0001). The levels (mean ± SD) of uric acid and hs‐CRP were significantly higher among women with pregnancy‐induced hypertension compared to normotensive pregnant women (p < 0.0001).Conclusion: This study indicated that pregnancy‐induced hypertension women have lipid abnormalities, increased systemic inflammatory markers, and hyperuricemia compared to normotensive pregnant women. Thus, women with PIH showing high dyslipidemia, hyperuricemia, and inflammation are likely to develop hypertension. Therefore, evaluation of these potential biomarkers during early antenatal care services may help seek interventions in PIH.Keywords
Funding Information
- Addis Ababa University
This publication has 45 references indexed in Scilit:
- Serum Uric Acid as a Prognostic Marker of Pregnancy induced HypertensionJournal of South Asian Federation of Obstetrics and Gynaecology, 2012
- Pathophysiology of Lipoprotein Oxidation2012
- Relation Among the Plasma Triglyceride/High-Density Lipoprotein Cholesterol Concentration Ratio, Insulin Resistance, and Associated Cardio-Metabolic Risk Factors in Men and WomenThe American Journal of Cardiology, 2012
- Plasma uric acid remains a marker of poor outcome in hypertensive pregnancy: a retrospective cohort studyBJOG: An International Journal of Obstetrics & Gynaecology, 2012
- Estimation of Lipid Profile in Subjects of PreeclampsiaThe Journal of Obstetrics and Gynecology of India, 2011
- A Meta-Analysis of Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, and Apolipoprotein B as Markers of Cardiovascular RiskCirculation: Cardiovascular Quality and Outcomes, 2011
- Acute-phase proteins: As diagnostic toolJournal of Pharmacy and Bioallied Sciences, 2011
- Longitudinal changes of adiponectin, carbohydrate and lipid metabolism in pregnant women at high risk for gestational diabetesGynecological Endocrinology, 2010
- Pregnancy‐associated plasma protein‐A and C‐reactive protein levels in pre‐eclamptic and normotensive pregnant women at third trimesterJournal of Obstetrics and Gynaecology Research, 2009
- Desirable Components of a Screening Lipid ProfileLaboratory Medicine, 2003